Exercise and Botulinum Toxin for Arm Stiffness After Stroke
Tests a prescribed exercise program alongside botulinum toxin in adults with post-stroke arm stiffness.
Plain-language title generated from the registry record
Registry title: Goal Attainment Scaling in Upper Limb Spasticity Treatment
Key facts
- Where
- Ljubljana, SloveniaSee the site
Where in Slovenia
- University Rehabilitation Institute, Republic of SloveniaLjubljana, SloveniaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Rehabilitation Institute, Republic of Slovenia
- Trial code
- NCT04975646
- Record updated
- 15 June 2026
- Original description
Patients after stroke with upper limb spasticity treated with botulinum toxin-A (BTX-A) will be included in this two-part study. In the first part, goal attainment scaling and comprehensive assessment of motor functioning will be performed before BTX-A application and after two weeks. In the second part, the patients will be randomised into a test group performing prescribed regular exercise for two weeks and a control group exercising at their own discretion during the same period, whereby the patients' health-related quality of life will be assessed at the beginning and end of the two-week period.Read full original descriptionShow less
Goal Attainment Scaling in Upper Limb Spasticity Treatment With Botulinum Toxin and the Influence of Regular Exercise for Spastic Upper Limb on Quality of Life in Patients After Stroke
Patients after stroke with upper limb spasticity treated with botulinum toxin-A (BTX-A) will be included in this two-part study. In the first part, goal attainment scaling and comprehensive assessment of motor functioning will be performed before BTX-A application and after two weeks. In the second part, the patients will be randomised into a test group performing prescribed regular exercise for two weeks and a control group exercising at their own discretion during the same period, whereby the patients' health-related quality of life will be assessed at the beginning and end of the two-week period.
Inclusion: patient's or caregiver's approval; ischemic or hemorrhagic stroke diagnosed using head CT/MRI; at least one upper limb muscle spasticity (MAS ≥ 3); candidate for BTX-A treatment or already given BTX-A in the past; patient's or caregiver's capability for goal attainment protocol cooperation (Mini Mental Examination ≥ 24 points).
Exclusion: other neurological or musculoskeletal diseases that could affect the treatment outcome; aphasic patients without caregiver's presence.